Vector-borne diseases (VBDs) represent a significant public health challenge in India, responsible for substantial morbidity and mortality. This article aims to provide a comprehensive review of VBDs in India, with a focus on understanding their prevalence and developing effective strategies to combat them.
India's diverse topography and climatic conditions contribute to the prevalence of various VBDs. Malaria, dengue, and chikungunya are the most commonly reported, while emerging diseases like Zika and Kala-azar also pose significant threats. The World Health Organization estimates that India accounts for 89% of South-East Asia's VBDs, highlighting the urgency of addressing this issue.
Several factors contribute to the difficulty in managing VBDs in India. These include a lack of public awareness, inadequate health infrastructure, rapid urbanization, and climate change. Additionally, the high genetic variability of vectors and pathogens complicates the development of effective vaccines and therapeutics.
Efforts to control VBDs in India should focus on integrated vector management, including environmental management and biological control methods. Enhanced surveillance systems, community participation, and intersectoral coordination are crucial. Furthermore, investment in research and development for effective vaccines and therapeutics is imperative.
Healthcare professionals play a pivotal role in combating VBDs. They are instrumental in early detection and prompt treatment, reducing disease transmission. Additionally, they can contribute to public health education, promoting preventive measures and improving community engagement in control programs.
Addressing the burden of VBDs in India requires a comprehensive, multi-faceted approach. Understanding the epidemiology, overcoming challenges, and implementing effective control strategies are key. Healthcare professionals, with their unique roles and responsibilities, are critical in this endeavor, underscoring the need for continuous professional development in this area.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation